Mogensen UM, Andersson C, Fosbl EL, Schramm TK, Vaag A, Scheller NM, Torp-Pedersen C, Gislason G, Kber L
kids live with parents with substance use disorders People taking semaglutide had lower risk of suicidal thoughts Scientists find common brain network for substance use disorders Few are prescribed medications to treat alcohol problems Repurposed drug combats obesity in mice Alcohol-related deaths increasing nationwide Understanding alcohol use disorder Understanding alcohol drinking patterns Alcohol treatment navigator References Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial
This pain can range from mild to severe and may intensify rapidly
The fact that it is now achievable with a weekly injection represents one of the most significant advances in metabolic medicine in decades
In the late 1980s, researchers began asking a deceptively simple question: How does an animal that eats so infrequently manage its blood sugar
GLP-1s: Seizing Opportunity in a New CPG Landscape leads you through a detailed exploration of the GLP-1 user journey, delivering a consumer-centric understanding of the attitudinal, behavioral, commercial and cultural disruption emerging from GLP-1 adoption
